000 01527 a2200457 4500
005 20250518083340.0
264 0 _c20210201
008 202102s 0 0 eng d
022 _a1365-2141
024 7 _a10.1111/bjh.16483
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBoccon-Gibod, Clémentine
245 0 0 _aCarfilzomib, venetoclax and dexamethasone for relapsed/refractory multiple myeloma.
_h[electronic resource]
260 _bBritish journal of haematology
_c05 2020
300 _ae73-e76 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xpharmacology
650 0 4 _aBridged Bicyclo Compounds, Heterocyclic
_xpharmacology
650 0 4 _aDexamethasone
_xpharmacology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMultiple Myeloma
_xdrug therapy
650 0 4 _aNeoplasm Recurrence, Local
650 0 4 _aOligopeptides
_xpharmacology
650 0 4 _aSulfonamides
_xpharmacology
700 1 _aTalbot, Alexis
700 1 _aLe Bras, Fabien
700 1 _aFrenzel, Laurent
700 1 _aRoyer, Bruno
700 1 _aHarel, Stephanie
700 1 _aLombion, Naelle
700 1 _aBelhadj, Karim
700 1 _aCuccuini, Wendy
700 1 _aArnulf, Bertrand
773 0 _tBritish journal of haematology
_gvol. 189
_gno. 3
_gp. e73-e76
856 4 0 _uhttps://doi.org/10.1111/bjh.16483
_zAvailable from publisher's website
999 _c30590143
_d30590143